Clinical trial
An Open-label, Multicenter, Multiple-dose, Phase III Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
NCT03765697 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Multicenter, Multiple-dose, Phase III Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
- Lead sponsor
- Grünenthal GmbH
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 16, 2003
- Completion date
- February 12, 2009
- Enrollment
- 259 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
post herpetic neuralgia